NLM Digital Collections

Search

Search Constraints

Start Over You searched for: Languages English Remove constraint Languages: English

Search Results

27811. Best practices for communication between IND sponsors and FDA during drug development: guidance for industry and review staff : good review practice

27812. Unique device identification: policy regarding compliance dates for class I and unclassified devices : immediately in effect guidance for industry and Food and Drug Administration staff

27813. Compounded drug products that are essentially copies of a commercially available drug product under Section 503A of the Federal Food, Drug, and Cosmetic Act

27816. Association of patient out-of-pocket costs with prescription abandonment and delay in fills of novel oral anticancer agents

27817. Experiences with the marrow nail operation according to the principles of Kuentscher

27818. Experiences with the marrow nail operation according to the principles of Kuentscher (Volume 1)

27819. Experiences with the marrow nail operation according to the principles of Kuentscher (Volume 2)

27820. Experiences with the marrow nail operation according to the principles of Kuentscher (Volume 3)